Teva bids $40bn for Mylan

22-04-2015

Teva bids $40bn for Mylan

Photo: Tevapharm.com

Pharmaceutical company Teva has offered to buy fellow drug maker Mylan in a deal that could be worth $40 billion.


Teva, Mylan, mergers & acquisitions

LSIPR